Home Blog Page 1756

EDL-Gen Signs an Agreement to Boost Floating Solar, Carbon Credit Initiatives

EDL-Gen partners with South Korea’s CS Tech to develop floating solar and carbon credit projects, advancing Laos’ green energy and sustainability goals. 10 November 2025. (Photo credit: EDL-Generation Public Company)

On 10 November, Électricité du Laos Generation Public Company (EDL-Gen) signed an agreement with South Korean firm CS Tech Co., Ltd. to develop floating solar installations on its hydropower reservoirs and advance carbon credit initiatives.

Souksavath Sosoupanh, Managing Director of EDL-Gen, stated that the partnership will install floating solar panels across EDL-Gen’s hydropower reservoirs, creating hybrid hydro-solar generation systems.

He added that the floating solar technology marks a significant step toward enhancing energy efficiency. 

“This agreement demonstrates our commitment to adopting innovative technologies to meet rising electricity demand while reducing carbon emissions,” he said during the ceremony.

EDL-Gen partners with South Korea’s CS Tech to develop floating solar and carbon credit projects, advancing Laos’ green energy and sustainability goals. Souksavath Sosoupanh, Managing Director of EDL-Gen (left) and Seo Dong-myeong, Managing Director of CS Tech (right). 10 November 2025. (Photo credit: EDL-Generation Public Company)

By utilizing reservoir surfaces, the project aims to boost energy output without requiring additional land while reducing water evaporation, according to EDL-Gen.

EDL-Gen partners with South Korea’s CS Tech to develop floating solar and carbon credit projects, advancing Laos’ green energy and sustainability goals. 10 November 2025. (Photo credit: EDL-Generation Public Company)

The collaboration also includes carbon credit development under Laos’Carbon Credit Decree, adopted in May 2025. 

The decree establishes a legal framework for registering and managing carbon projects through the Ministry of Agriculture and Environment, enabling Laos to participate in international carbon markets.

Expanding Solar and Sustainable Energy

EDL-Gen has been rapidly expanding its renewable energy capacity. The company previously signed agreements with ASFC Co., Ltd. for a 15-megawatt solar project near the Xeset 1-3, Xelabam, and Nam Mang 3 hydropower plants.

The partnership aims to attract clean energy investment and strengthen Laos’ position in global carbon markets, officials said.

Akhomdeth Vongsay, Vice Chairman of EDL-Gen, stated a mid-year review meeting in August that the company is advancing large-scale solar projects totaling 680 megawatts nationwide.

“THAI SELECT FESTIVAL” Brings the Authentic Flavors of Thailand to Los Angeles


LOS ANGELES, USA – Media Out Reach Newswire – 13 November 2025 – The Department of International Trade Promotion (DITP), Ministry of Commerce of Thailand, proudly announces the “THAI SELECT FESTIVAL”, a special event celebrating the excellence of Thai cuisine and the Thai SELECT certification mark in the western United States.

Key Visual Thai Select

The festival aims to advance Thailand’s Soft Power in gastronomy on the global stage through creative storytelling that blends food, culture, and art — presenting the warmth and authenticity of Thai culinary heritage to an international audience.

Her Royal Highness Princess Ubolratana Rajakanya Sirivadhana Barnavadi will graciously preside over the opening ceremony at The Cabana @ Westfield Century City in Los Angeles on November 17, 2025, marking an auspicious moment in Thailand’s ongoing mission to share its culinary heritage with the world.

This year’s festival embraces the theme “The Savory Thai SELECT Night Market”, inspired by the Thai concept of “aroi” — rich, flavorful, and irresistibly charming. The event recreates the colorful atmosphere of a Thai night market, filled with aromatic dishes, cheerful energy, and cultural creativity that reflects the true spirit of Thailand.

Visitors will enjoy a range of engaging experiences, including:

  • Thai SELECT Restaurants: More than 14 Thai SELECT-certified restaurants will present their signature dishes, allowing guests to savor authentic Thai flavors from across Thailand.
  • Cultural Zone: A lively area featuring the traditional Thai “Pa-Pao” dart game, where visitors can enjoy friendly fun and take home exclusive souvenirs.
  • Thai SELECT Passport: A culinary adventure where participants collect stamps from different booths for a chance to win special prizes presented by Thailand’s beloved actors Mile – Phakphum Romsaithong and Apo – Nattawin Wattanagitiphat, who will personally greet fans and present the awards.

The THAI SELECT FESTIVAL serves as a vibrant platform to celebrate and elevate the global image of Thai cuisine, reaffirming the value of the Thai SELECT mark as a trusted symbol of Authentic Thai Taste and promoting pride in Thailand’s rich culinary heritage.

Hashtag: #ThaiSELECT

The issuer is solely responsible for the content of this announcement.

Bairong Inc. and Shanghai Pudong Development Bank Establish Strategic Ecosystem partnership to Accelerate the Compliant Implementation of “Financial Agents”

BEIJING, Nov. 13, 2025 /PRNewswire/ — Bairong Inc. (the “Company”, “we” , “us” or “our” ; HKEX: 6608), a leading AI turnkey service provider, recently established a strategic ecosystem partnership with Shanghai Pudong Development Bank. Leveraging its cutting-edge technology architecture and extensive customer experience, Bairong Inc aims to accelerate the large-scale and intelligent development of “financial agents”, accelerating the financial industry entry into the AI era.

Bairong Inc. officially signed an in-depth strategic cooperation agreement with Shanghai Pudong Development Bank (Hong Kong Branch) and SPDB International Holdings Limited in November, 2025. Through this partnership, the parties will jointly explore the deep integration of finance and technology, build a long-term “AI + finance” strategic cooperation alliance, and create an open, intelligent, and mutually beneficial new ecosystem for bank-enterprise collaboration.

Bairong Inc. and Shanghai Pudong Development Bank Establish Strategic Ecosystem partnership to Accelerate the Compliant Implementation of "Financial Agents"
Bairong Inc. and Shanghai Pudong Development Bank Establish Strategic Ecosystem partnership to Accelerate the Compliant Implementation of “Financial Agents”

Against the backdrop of global digitalization and the rapid evolution of the artificial intelligence industry, technology has become a driving force behind the transformation of the financial industry.

As the first state-owned commercial bank in the industry to explore the technology-driven financial service model, SPD Bank has always attached great importance to the expansion and upgrading of its technology financial business. Focusing on the “five key tasks” of the Central Financial Work Conference, the bank has established a “digital intelligence” strategy, and has taken science and technology finance as its top strategic priority, continuously strengthening its presence in artificial intelligence, cloud computing and other fields.

At the same time, as a leading AI native technology enterprise in China, Bairong Inc. has long been deeply involved in the industrial application of artificial intelligence technologies.  The Company has developed a core technology framework that includes its AI agent platform (Bairong CybotStar), self-developed large model (BR-LLM), intelligent decision-making engine, intelligent risk control and marketing middle platform, and has consistently played a key role in the process of financial intelligent transformation.

Leveraging its “Result as a Service (RaaS)” business model, Bairong Inc. deeply integrates AI technology with financial business scenarios. Through its “silicon-based workforce” concept, it helps financial institutions build intelligent system architectures that are practical, evolvable and measurable, enabling end-to-end intelligent upgrades from front-end marketing to middle-office risk management and back-office operations, and accelerating the financial industry transition toward a new era of intelligence and efficiency.

The strong cooperation between SPD and Bairong Inc. is not only the result of a shared vision, but also the beginning of joint innovation in action.

Leveraging this strategic collaboration as an opportunity, the parties will fully integrate their technological strengths and resource advantages to carry out systematic joint development in key areas such as agent platform construction, AI-driven business innovation, intelligent risk management, and customer service enhancements. Bairong Inc. will provide SPD with customizable AI hubs and enterprise-level intelligent agent capabilities, empowering the bank to achieve AI-driven transformation across core functions such as intelligent financial management, credit decision-making, risk monitoring, cross-border finance, asset management, and customer operations, unleashing the multiplier effect of artificial intelligence across the entire financial value chain.

Amid the deep integration of technology and finance, a future-oriented intelligent financial practice is taking shape. Driven by innovation, empowered by intelligence, and connected through ecosystem collaboration, this strategic alliance between Bairong Inc. and Shanghai Pudong Development marks an important milestone in bank-enterprise integration, and sets a new benchmark for the new era of “AI + finance”. With the power of science and technology and the wisdom of finance, Bairong Inc. will join hands with its partners to embark on the boundless journey toward the intelligent economy.

About Bairong

Bairong Inc. is a leading enterprise-level AI application service provider, delivering AI Agent to institutional clients through its Results-as-a-service (RaaS) business model. The Company applies large language models (LLMs), reinforcement learning (RL), retrieval-augmented generation (RAG), multimodal intelligence, natural language processing (NLP), deep machine learning, digital human 3D engines, privacy computing, cloud computing and other technologies. Leveraging its proprietary BR-LLM large language model and its agent buidling system Bairong CybotStar(百融百工), the Company enables clients to automate end-to-end internal operations management and external business transactions. Both “Bairong CybotStar(百融百工)” and BR-LLM have completed national regulatory registration. The Company holds over 95% of intellectual property rights among its product portfolio, and a total of 461 software copyrights and patents as of June 30, 2025. Bairong serves more than 8,000 institutional customers across industries including finance, internet, retail, communications, education and healthcare, with AI Agent services applied in scenarios such as marketing recommendation and sales collaboration, intelligent customer service and outbound calls, contract, invoice and system analysis, credit assessment and fraud prevention, claims settlement and records management, as well as recruitment and operations and training empowerment.

For more information, please visit: http://ir.brgroup.com

Safe Harbor Statement

This press release contains statements that may constitute “forward-looking” statements. These forward-looking statements can be identified by terminologies such as “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “likely to,” and the negative of these words and other similar expressions or statements. Bairong may also make written or oral forward-looking statements in its periodic reports to the HKEx, in its annual and interim reports to shareholders, in press releases and other written materials, and in oral statements made by its officers, directors, or employees to third parties. Statements that are not historical facts, including statements about Bairong’s beliefs, plans, and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statements, including but not limited to the following: Bairong’s strategies, future business development, and financial condition and results of operations; Bairong’s limited operating history; risks associated with the financial service industry, Bairong’s ability to develop and deliver services of high quality and appeal to clients; Bairong’s ability to generate positive cash flow and profits; Bairong’s ability to compete successfully; Bairong’s ability to build its brand and withstand negative publicity; and changes in client demand and government incentives, subsidies, or other favorable government policies. Further information regarding these and other risks is included in Bairong’s filings with the HKEX. All information provided in this press release is as of the date of this press release, and Bairong does not undertake any obligation to update any forward-looking statements, except as required under applicable laws.

For investor inquiries, please contact:
Bairong Inc.
Ms. Sandy Qin, CFA, CMA, FCG HKFCG
Email: ir@brgroup.com

For media inquiries, please contact:
Bairong Inc.
Email: brmarketing@brgroup.com

Strengths School™ Unites Asia’s Top HR Leaders at Inaugural Conference in Hong Kong Unlocking Peak Employee Engagement with Strengths-Based Strategies

HONG KONG, Nov. 13, 2025 /PRNewswire/ — Strengths School™, Singapore’s trusted provider of strengths-based training, successfully hosted its inaugural HR conference on 7 November. The event, hosted by Jason Ho, Founder of Strengths School™, gathered distinguished HR directors and senior managers, talent management, and L&D leaders across Asia from notable brands including Deloitte, Lululemon and Swire Properties, in an insightful exploration of strength-based practices that boost employee engagement in workplaces.

Under the theme of “Increasing Engagement with Strengths”, the conference provided a dynamic platform for senior HR professionals to learn research-backed tools based in positive psychology, and utilise them for identifying and leveraging unique employee strength profiles within their organizations. The interactive agenda featured networking opportunities, an interactive discussion session among guests, and a live CliftonStrengths® demo workshop that equipped attendees with practical tools for talent coaching, team building, and constructing resilient, high-performing workplace cultures.

Reflecting on the event’s success, Jason Ho, Founder of Strengths School™, shared: “Our mission is built on a simple but powerful truth: great teams are built when every individual’s unique strength is embraced. At this conference, our goal was to move the conversation from abstract theory to practical strategy. By giving HR leaders a hands-on demonstration of the CliftonStrengths® framework, we equipped them with a proven methodology to directly impact engagement, productivity, retention and ultimately, the bottom line.”

The inaugural conference by Strengths School™ set a new benchmark for HR events in Asia, emphasising research-backed, actionable insights and peer-to-peer learning. It underscores the growing demand for strengths-based development as a critical driver for employee engagement in today’s ever-evolving businesses.

For more information or to schedule a discovery session, visit https://www.strengthsschool.com/

Media Enquiries  

For further enquiries and requests for interviews, please contact:   

Occasions PR & Marketing Ltd.  

Name:  Alvina Lam

Email: alvina@occasionspr.com

Tel: +852 3678 0170

Name: Peter Cheung

Email: petercheung@occasionspr.com

Tel: +852 3678 0114

 

About Strengths School

Strengths School™ is a Singapore-based consultancy specializing in strengths-based development for individuals, teams, and leaders. We deliver engaging, results-driven programs that improve performance, collaboration, and employee engagement. Our flagship programs — TeamEDGE™, LeadershipEDGE™, and TalentEDGE™ — have been adopted by leading organizations across Asia.

National Assembly Calls for Action on Roads, Education, Agriculture

National Assembly Calls for Action on Roads, Education, Agriculture
Suayphet Thongsombath, NA member for the 8th constituency of Houaphan Province, who highlighted the severe deterioration of Road No. 6. (photo credit: Pasaxon)

At the 10th Ordinary Session of the 9th National Assembly on 11 November, members proposed measures for the government to address key challenges highlighted in the national socio-economic development plan, state budget, and monetary plan, calling for urgent improvements in infrastructure, education, governance, and sustainable development.

JM Flower Launches Limited-Time Early Bird & Black Friday Christmas Sale – Christmas Trees & Christmas Gifts with Free Shipping!

SINGAPORE, Nov. 13, 2025 /PRNewswire/ — JM Flower, Singapore’s leading florist and gift specialist, is spreading the festive cheer early this year with an exclusive Early Bird + Black Friday Sale across its Christmas Trees and Christmas Gifts Arrangements & Hampers.

Early Bird + Black Friday Christmas Sale
Early Bird + Black Friday Christmas Sale

From now until 30 November 2025, shoppers can enjoy up to 21% off JM Flower’s premium holiday essentials and gifts — from fresh, real Noble Fir Christmas Trees to festive floral arrangements, mini trees, wreaths, and gift bundles. Perfect for decking the halls or delighting loved ones, this Early Bird + Black Friday Sale brings together the best of JM Flower’s Christmas Trees and Gifts Collection, complete with free delivery and no minimum spend.

Early Bird + Black Friday Sale Highlights

Christmas Trees Collection – Shop Now
 Transform your home into a winter wonderland with JM Flower’s collection of real, live Noble Fir Christmas trees directly imported from premium farms in Europe, freshly cut, naturally fragrant, and ready to bring the holiday spirit into homes.

The trees are delivered in a hassle-free manner: they arrive at the customer’s doorstep already set up and ready to enjoy.

Christmas Gifts Collection – Shop Now
 Find thoughtful presents that express love and warmth this festive season.

  • Up to 20% OFF on a curated range of festive items: mini Christmas trees, wreaths, DIY kits, floral arrangements, and gift bundles.
  • Free Shipping, No Minimum Spend
  • Ideal for festive gifting and year-end celebrations

Celebrate the Holidays with JM Flower

“Our annual Christmas sale is our way of thanking our customers and helping them celebrate the season with style and joy,” said a JM Flower spokesperson. “From elegant trees to heartfelt gifts, we want every home and office to feel the magic of Christmas, without breaking the budget.”

*This limited-time promotion runs until 30 November 2025, while stocks last.

Shop Now & Save Big

Promotion Period: Now until 30 November 2025
Discounts: Up to 21% Off + Free Shipping

About JM Flower

JM Flower is a Singapore-based wholesaler florist and lifestyle brand offering artfully designed floral arrangements, premium gifts, and seasonal décor. Known for its creativity and commitment to quality, JM Flower makes gifting easy and meaningful for every occasion.

Citi Reiterates “Buy” Rating on Fosun International and Lifts Target Price to HK$6.5


HONG KONG SAR – Media OurReach Newswire – 13 November 2025 – Citi hosted its 2025 China Conference this week and released an updated research report on Fosun International (00656.HK), reiterating its “Buy” rating and raising the target price to HK$6.5.

Citi remains positive on Fosun’s business streamlining and core business-focused strategy. Following a series of recent meetings with Fosun’s management team, Citi noted that the discussions reflected a clear strategic direction. Management has indicated that Fosun will continue to focus on its core businesses, deepen its global presence, and continue to step up innovation efforts.

Citi also notes Fosun’s ongoing efforts to optimize its financial structure and highlights its firm commitment to deleveraging and divesting non-core assets. Fosun’s business streamlining approach will not only enhance financial resilience but also sharpen the Group’s strategic focus on core businesses to unlock long-term value. UBS, in its latest research report, also notes Fosun’s proactive steps to dispose non-core assets, optimize its asset portfolio, and increase cash flow amid improving equity market sentiment and valuation, thus raising the target price for Fosun International.

In fact, multiple domestic and international securities firms, including Citi, Industrial Securities, Kaiyuan Securities, Huaxi Securities, SDIC Securities, China Securities, and Founder Securities, currently hold “Buy” or “Overweight” ratings on Fosun International, with target prices ranging from HK$6.5 to HK$7.5. They are confident in Fosun’s solid business resilience and innovation-driven growth. Citi highlights that Fosun’s health and insurance businesses will provide long-term profit momentum for the Group, while securities firms such as Industrial Securities and Huaxi Securities remain upbeat on the sustained breakthroughs in Fosun’s core cultural tourism and consumer businesses.

Powered by continuous innovation, Fosun’s Health segment has achieved multiple breakthroughs in the field of innovative drugs, earning strong endorsements from securities firms. Among which, HANSIZHUANG, an anti-PD-1 monoclonal antibody independently developed by Fosun, has become the world’s first anti-PD-1 monoclonal antibody approved for the first-line treatment of small cell lung cancer (SCLC). To date, it has been approved for marketing in nearly 40 countries and regions, including China, the European Union, the United Kingdom, Singapore, and India. Additionally, HLX43, a PD-L1-targeting antibody-drug conjugate (ADC) independently developed by Fosun, is undergoing clinical studies for solid tumors such as non-small cell lung cancer and thymic carcinoma in countries including China, the United States, and Australia. Currently, no PD-L1 ADC has been approved globally, positioning HLX43 as a potential highly effective and safe broad-spectrum anticancer drug.

In the insurance business, Fidelidade maintained steady growth in 2024. It recorded a 12.7% year-on-year increase in insurance income, with net profit for the full year reaching EUR253 million. In July 2025, S&P assigned Fidelidade an “A” rating. It anticipates that, over the next two years, Fidelidade will continue to maintain its leading positions in both Portugal and international markets, and sustain robust capital strength and profitability to achieve steady growth.

In the cultural tourism business, during the National Day and Mid-Autumn Festival holidays in 2025, Taicang Alps International Resort welcomed over 50,000 visitors, while Lijiang Club Med Resort reported full occupancy for three consecutive days. In addition, the six resorts of Club Med Urban Oasis and Club Med Joyview saw their average daily room rates increase nearly 10% year-on-year. In particular, the Heilongtan resort sustained an occupancy rate above 94% for six consecutive days, driving a 36% year-on-year increase in total business volume for Club Med in China and a 213% surge in inbound tourists. Meanwhile, Atlantis Sanya achieved a 20% year-on-year increase in average daily room rate, further consolidating its leadership in the high-end resort market.

In the consumer business, securities firms note that Yuyuan is accelerating adjustments to its overall operating strategy. While short-term earnings are experiencing pressure, the jewelry segment’s results indicate the company has entered the latter stage of its adjustment cycle, with core businesses gradually recovering. Citi also highlights the positive sequential momentum in Yuyuan’s gold and jewelry business, demonstrating the resilience of Fosun’s consumer portfolio. The market broadly anticipates that with a moderate recovery in the consumer market, the establishment of the Shanghai International Jewelry & Style District, and the deepening of global presence, Yuyuan is poised to establish new growth drivers in core areas such as jewelry fashion and commercial operations, unlocking greater growth potential.

Fosun continues to promote innovation in asset management and fintech, gaining recognition from domestic and international securities firms including Citi. In the research report, Citi highlights Fosun’s increased resources and attention to fintech and Web3.0 businesses and notes that its subsidiary Finloop Finance Technology has emerged as a leading fintech company in the Hong Kong market. Incubated by Fosun Wealth, Finloop Finance Technology is positioned as an AI-driven, one-stop Web5 (Web2 + Web3) wealth technology platform with licensed operations in Hong Kong. Huaxi Securities and SDIC Securities highlight that Finloop Finance Technology is making steady progress in the virtual asset market with the launch of its FinRWA platform. Powered by a proprietary research and development system, the FinRWA platform provides enterprises and financial institutions with compliant and efficient access to Web3, supporting tokenized issuance and distribution of both public and private funds. It has already executed several innovative projects, including the launch of the Hong Kong’s first platform for multi-currency tokenized funds, facilitating the rollout of Hong Kong’s first tokenized fund under a unit trust structure, and the debut of Asia’s first comprehensive technical solution for “Hong Kong Stock Performance-Linked Token”. In April this year, Finloop Finance Technology was recognized by the Office for Attracting Strategic Enterprises (OASES) of the Government of the Hong Kong Special Administrative Region as one of its key enterprises.

Multiple securities firms note that Fosun’s core businesses are operating steadily. With a continued focus on industries of strength and potential, Fosun is deepening its global presence and intensifying its technology innovation efforts, thereby shaping a resilient business framework capable of withstanding economic cycles. Consequently, these firms maintain an optimistic outlook on Fosun International’s long-term growth.

Hashtag: #Fosun

The issuer is solely responsible for the content of this announcement.

Agilent and National Heart Centre Singapore Sign Agreement to Advance Metabolic Heart Failure Research

Research focuses on human cardiac organoids to uncover metabolic drivers of heart failure and accelerate new therapeutic strategies to improve cardiovascular outcomes

SINGAPORE, Nov. 13, 2025 /PRNewswire/ — Agilent Technologies Inc. (NYSE: A) announced the signing of a five-year Memorandum of Understanding (MOU) with National Heart Centre Singapore (NHCS) to accelerate innovation in metabolic heart failure research, one of the most complex and underserved areas in cardiovascular medicine.

(from right) Asst. Prof Chrishan Ramachandra, Principal Investigator of National Heart Research Institute Singapore (NHRIS) at National Heart Centre Singapore (NHCS), Prof. Derek Hausenloy, Director of NHRIS at NHCS, Dr Charmian Cher, Associate Vice President of Field Marketing for APAC at Agilent, and Dr Samir Vyas, Associate Vice President of Sales for APAC at Agilent, during the signing ceremony at Biopolis in Singapore.
(from right) Asst. Prof Chrishan Ramachandra, Principal Investigator of National Heart Research Institute Singapore (NHRIS) at National Heart Centre Singapore (NHCS), Prof. Derek Hausenloy, Director of NHRIS at NHCS, Dr Charmian Cher, Associate Vice President of Field Marketing for APAC at Agilent, and Dr Samir Vyas, Associate Vice President of Sales for APAC at Agilent, during the signing ceremony at Biopolis in Singapore.

 

Agilent Seahorse XF Flex Analyzer 3D Workflow Features Metabolic Profile that Serves as Dynamic Biomarkers of Cell Health

Heart failure remains a leading global cause of death and disability¹, with metabolic forms such as diabetic heart failure and heart failure with preserved ejection fraction (HFpEF) posing challenges due to limited treatment options². Under this agreement, Agilent and NHCS will combine their expertise in human cardiac organoids using human-derived heart tissues with cutting-edge analytical technologies, including Agilent’s latest Seahorse XF Flex Analyzer which expands real-time metabolic analysis into 3D tissues and organoid workflows to investigate metabolic drivers of heart failure.

“Our collaboration with Agilent allows us to advance the study of heart disease using patient-specific beating heart cells. By combining NHCS’s expertise with Agilent’s advanced technology, we can detect the earliest changes in how heart cells use energy before visible damage occurs. This accelerates the discovery of new therapies and safely testing them, ultimately offering hope to heart failure patients who currently have limited treatment options,” said Prof Derek Hausenloy, director of the National Heart Research Institute Singapore (NHRIS) at NHCS.

NHCS has established itself as a leader in modelling monogenic cardiac diseases using patient-specific induced pluripotent stem cells (iPSCs), which led to novel therapeutic targets now undergoing clinical evaluation³,⁴. Building on this foundation, the integration of Agilent’s next-generation technology and NHCS’s Preclinical Platform for Development of Therapeutics for Heart Failure (PREVENT-HF) positions the collaboration to provide hypotheses for clinical validation, offering new insights into disease progression, novel therapeutic development, and assessment of treatment safety and efficacy in clinically relevant models.

“Together with NHCS, we are bridging science and technology to reimagine how metabolic heart failure is understood and treated through translational research. This partnership reflects our shared commitment to addressing the unmet needs in cardiovascular care while strengthening our leadership in the biomedical ecosystem, positioning us at the frontier of cardiovascular research locally, regionally, and globally.” Said Bharat Bhardwaj, vice president of APAC sales at Agilent.

Over the past decade, Agilent has made significant contributions to research advancement aimed at improving population health in Singapore. In 2019, the National University of Singapore (NUS), National University Hospital (NUH), and Agilent launched a $38 million research hub to boost clinical diagnostics and biochemistry testing.

Last year, Agilent partnered with NUS, acting through the Yong Loo Lin School of Medicine (NUS Medicine), established the NUS-Agilent Center of Excellence in Cell Metabolism in support of the Singapore Ministry of Health’s Project RESET, Cardiovascular Metabolic Disease Translational Research Programme (CVMD-TRP) and PREVENT-HF to accelerate the discovery of novel insights into the complex mechanisms of heart disease.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers’ most challenging questions. The company generated revenue of $6.51 billion in fiscal year 2024 and employs approximately 18,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and Facebook.

About the National Heart Centre Singapore

The National Heart Centre Singapore (NHCS) is a leading national and regional referral centre for cardiovascular diseases, offering 185 beds and a comprehensive range of cardiac care services from preventive to rehabilitative. Ranked #12 as the World’s Best Cardiology Hospital by Newsweek 2025, NHCS’s clinical outcomes are consistently recognized at the international level, meeting or exceeding global standards. It is also the only facility in Singapore providing heart and lung transplantation programme.

As an academic medical centre, NHCS is committed to training healthcare professionals and advancing cardiovascular health through cutting-edge translational research in collaboration with local and international collaborators.

For more information, please visit: www.nhcs.com.sg

Media Contacts

Grace Thong

Agilent Technologies 

+65 9688 2152

grace.thong@agilent.com

 

Belinda Lim

National Heart Centre Singapore

+65 9689 7453

Belinda.lim.s.m@nhcs.com.sg

 

1 https://www.who.int/health-topics/cardiovascular-diseases#tab=tab_1 

2 Ramachandra, C. J. A., Hernandez-Resendiz, S., Crespo-Avilan, G. E., Lin, Y. H. & Hausenloy, D. J. Mitochondria in acute myocardial infarction and cardioprotection. EBioMedicine 57, 102884, doi:10.1016/j.ebiom.2020.102884 (2020).

3 Mehta, A. et al. Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model. European heart journal 39, 1446-1455, doi:10.1093/eurheartj/ehx394 (2018).

4 Ramachandra, C. J. A. et al. Inhibiting cardiac myeloperoxidase alleviates the relaxation defect in hypertrophic cardiomyocytes. Cardiovascular research 118, 517-530, doi:10.1093/cvr/cvab077 (2022).